MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cancer test'. Sat, 03 Sep 2011 03:00:51 +0100 http://www.medworm.com/index.php?rid=1847876&cid=t_182789_125_f&fid=34820&url=http%3A%2F%2Fwww.dentalblogs.com%2Farchives%2Fadministrator%2Fdentistry-news-oral-cancer-detection-with-saliva%2F Proteins in saliva may reveal oral squamous cell carcinoma, a serious and often undetected disease that claims the lives of more than 7500 Americans each year. The news was posted in Clinical Cancer Research, October 1, 2008 issue, as a result of Dr. David T. Wong’s research at University of California, Los Angeles School of Dentistry. Wong works with the Human Saliva Proteome Project, an undertaking begun by the National Institute of Dental and Craniofacial Research. Learn more about oral cancer at Oral Cancer Foundation. Currently, ViziLite and VELscope are early detection systems used in dental checkups. SOURCE: Medical News Today (Source: dental blog for dentists about dentistry) dental blog for dentists about dentistry blogs http://www.medworm.com/rss/comments.php?id=1847876 Thu, 02 Oct 2008 14:13:54 +0100 1847876 http://www.medworm.com/index.php?rid=1445892&cid=t_182789_125_f&fid=34820&url=http%3A%2F%2Fwww.dentalblogs.com%2Farchives%2Fadministrator%2Falcohol-increases-cancer-risk-by-75%2F Wine is good for the heart, they say, but two glasses of an alcoholic beverage each day can increase the risk of oral cancer, as well as breast, bowel, and throat cancer, by 75%. In the UK, health experts are working hard to encourage smoking cessation, as well. As of September 30, 2008, gruesome photos of the effects of oral and throat cancer are being posted on every pack of cigarettes. Tobacco and alcohol are primary risk factors for acquiring oral cancer. How many people actually have oral cancer? You’ll find this startling statement on the Oral Cancer Foundation website: “More than 34,000 Americans will be diagnosed with oral or pharyngeal cancer this year. It will cause over 8,000 deaths, killing roughly 1 person per hour, 24 hours per day. Of those 34,000 newly diagnose... dental blog for dentists about dentistry blogs http://www.medworm.com/rss/comments.php?id=1445892 Thu, 15 May 2008 13:36:59 +0100 1445892 http://www.medworm.com/index.php?rid=1150892&cid=t_182789_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F216892947%2F Approved by the FDA, a genetic test that can help in the assessment of risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer - TOP2A FISH pharmDx - is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients. The TOP2A gene plays a role in DNA replication. The TOP2A FISH pharmDx test uses fluorescently labeled DNA probes to detect or confirm gene or chromosome abnormalities, a technology known as fluorescent in situ hybridization (FISH). The recurrence of cancer depends partly on certain genes whose activity may be altered by changes in the number of gene copies in the tumor. Changes in the TOP2A gene in breast cancer cells mean there is an increased likelihood that the tumor will recur or that long-term ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1150892 Tue, 15 Jan 2008 07:43:00 +0100 1150892 http://www.medworm.com/index.php?rid=1070263&cid=t_182789_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F195017707%2Fagendias_mammaprint_named_time.html MammaPrint, a breast cancer test invented and developed by the Dutch company Agendia, was named one of Time magazine's Best Invention's of 2007.The test, called "Cancer's Crystal Ball" gives additional information on a patient's tumor to aid in deciding the best course of treatment by measuring the level of activity in 70 genes taken from a sample from a surgically removed breast cancer tumor. Then, using specific algorithms, it determines whether there is a high or low risk of the cancer spreading to other parts of the body. That determination helps doctors determine the next course of treatment and can mean less aggressive therapies are chosen. MammaPrint is the first test of its kind to be market approved by the U.S. Food and Drug Administration."We a... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1070263 Tue, 04 Dec 2007 15:00:26 +0100 1070263